Clinical Trials Directory

Trials / Completed

CompletedNCT00901056

Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction

Feasibility Study to Investigate the Effect of Low Intensity Shockwaves on Patients With Erectile Dysfunction Resulted From Vascular Origin

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Medispec · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Low intensity shockwaves have been proven in animal studies to induce local growth of new blood vessels from existing ones. The hypothesis of this study is that shockwave therapy could improve the symptoms of patients with erectile dysfunction resulted from a vascular origin and respond to PDE-5 inhibitors.

Detailed description

Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered to the penile tissue. Shockwaves are created by a special generator and are focused using a specially designed shockwave applicator apparatus. The shockwaves are delivered trough the applicator covering the corpora cavernosa of the penis.

Conditions

Interventions

TypeNameDescription
DEVICEExtracorporeal Shockwave TherapyEnergy Density - 0.02 - 0.15 mJ/mm2

Timeline

Start date
2008-11-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2009-05-13
Last updated
2011-01-25

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00901056. Inclusion in this directory is not an endorsement.

Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction (NCT00901056) · Clinical Trials Directory